The Motley Fool

Incyte Aktie (NASDAQ:INCY)

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

$68.68 $-0.58 (-0.01) Dienstag, 28. September 2021 um 22:00:00 Mitteleuropäische Sommerzeit

About

Last updated 28-09-2021, 10:00:00pm CEST
Aktueller Kurs $68.68
Veränderung $-0.58 (-0.8%)
Schlusskurs $68.68
Eröffnung $69.07
Geld $68.41
Brief $70.00
Tagesspanne $68.55 - $69.63
52-Wochen-Spanne $67.87 - $101.47
Volumen 1,156,541
Durchschn. Volumen 1,351,370
Marktkapitalisierung $15,295,050,730.00
EPS (roll. Hochrechn.) $1.54

Related Articles